Articles

Read the latest articles relevant to your clinical practice, including exclusive insights from Healthed surveys and polls.

By reading selected clinical articles, you earn CPD in the Educational Activities (EA) category whenever you click the “Claim CPD” button and follow the prompts. 

Dr Linda Calabresi

The COVID vaccine rollout is certainly moving forward admirably. Authorities are predicting at this rate we might reach our 70% target in November and the 80% target by the end of the year

Dr Linda Calabresi

We now have the target. We know we need to get up around the 70-80% mark in terms of vaccination coverage before we can start to think about getting back to some semblance of normality here in Australia.

Dr Linda Calabresi

You might think that after the phenomenal effort general practice has put in to vaccinate the Australian population against COVID, that they’d be entitled to say ‘let someone else do the boosters.’

Healthed

India lacks an authoritative estimate of the death toll from the COVID-19 pandemic. We report excess mortality estimates from three different data sources from the pandemic’s start through June 2021.

Dr Linda Calabresi

The vast majority of Australian GPs believe that COVID vaccination should be mandatory for all those who work in general practice.

Dr Linda Calabresi

As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.

Dr Brett Montgomery

It has been a wild week for public messaging about the AstraZeneca COVID-19 vaccine — baffling both for the public and for general practitioners like me.

Dr Linda Calabresi

If you’re like the majority of general practices in Australia, you will be flat out juggling consents, documents and actual jabs be it AstraZeneca and/or Pfizer in the quest to conquer COVID.

Dr Linda Calabresi

Well, if nothing else, it looks as though GPs are ready to race through to stage 4 of the COVID recovery plan.

A/Prof Nicholas Wood

Pfizer remains the “preferred” vaccine for Australians aged under 40, due to a small but real increased risk of a rare clotting disorder.

Dr Linda Calabresi
Prof Paul Griffin